share_log

HCA Healthcare | 8-K: HCA Healthcare reports THIRD quarter 2024 results

SEC ·  Oct 25, 2024 19:42

Summary by Futu AI

HCA Healthcare reported Q3 2024 revenues of $17.487 billion, with net income reaching $1.270 billion or $4.88 per diluted share. Same facility admissions increased 4.5%, while emergency room visits rose 4.6% compared to Q3 2023. The results include a $0.15 per share impact from Hurricane Helene.The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts. Hurricane-related expenses and revenue losses are estimated at $200-300 million for Q4 2024. Operating cash flows strengthened to $3.515 billion, up from $2.479 billion in Q3 2023.The Board declared a quarterly cash dividend of $0.66 per share, payable on December 27, 2024, to stockholders of record on December 13, 2024. During Q3, the company repurchased 4.948 million shares for $1.795 billion, with $2.433 billion remaining under its repurchase authorization.
HCA Healthcare reported Q3 2024 revenues of $17.487 billion, with net income reaching $1.270 billion or $4.88 per diluted share. Same facility admissions increased 4.5%, while emergency room visits rose 4.6% compared to Q3 2023. The results include a $0.15 per share impact from Hurricane Helene.The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts. Hurricane-related expenses and revenue losses are estimated at $200-300 million for Q4 2024. Operating cash flows strengthened to $3.515 billion, up from $2.479 billion in Q3 2023.The Board declared a quarterly cash dividend of $0.66 per share, payable on December 27, 2024, to stockholders of record on December 13, 2024. During Q3, the company repurchased 4.948 million shares for $1.795 billion, with $2.433 billion remaining under its repurchase authorization.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.